StockData
Aktis Oncology, Inc. logo

Aktis Oncology, Inc. (AKTS) stock

AKTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$16.31+0.15 (+0.93%)

Close on Nov 17, 2026Market cap $907.15MP/E –Yield –

Aktis Oncology total assets

Total assets on the balance sheet at the end of each period.

Aktis Oncology's total assets was $532.48M at Sep 30, 2026. For fiscal 2025 it was $264.89M.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$264.89M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$532.48M–
Q2 FY2026Jun 30, 2026$557.60M–
Q1 FY2026Mar 31, 2026$576.80M–
Q4 FY2025Dec 31, 2025$264.89M–

More Aktis Oncology figures

See a number that looks wrong?